SightfileU.S. market data from official filings

Companies › RNTX

REIN THERAPEUTICS INC (RNTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001420565 · EDGAR filings · Updated 2026-07-21

REIN THERAPEUTICS INC (RNTX) has reported institutional ownership of 40.6%, with 46 institutional managers holding positions valued at $14.8M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
40.6%
Institutional managers
46
Reported 13F value
$14.8M
Insider activity
5 trans.
$550.6K net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, REIN THERAPEUTICS INC has 46 institutional holders and institutional ownership of 40.6%.

Insider activity

Insiders reported 5 transactions (5 buys, 0 sells) across 2 reporting insiders, with a net reported value of $550.6K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-26 (recurring since 2020-03-30) — source filing. The authoritative details are those stated in the filing itself.

Related companies

SENSUS HEALTHCARE INC (SRTS) · Hyperfine Inc (HYPR) · FORTRESS BIOTECH INC (FBIO) · NEURAXIS INC (NRXS) · PARK DENTAL PARTNERS INC (PARK) · MOLECULAR PARTNERS AG (MOLN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.